Last: | $1 |
---|---|
Change Percent: | 0.0% |
Open: | $1.05 |
Close: | $1 |
High: | $1.05 |
Low: | $0.99 |
Volume: | 26,789 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1 | $1.05 | $1 | $1.05 | $0.99 | 26,789 | 07-04-2024 |
$1 | $1.05 | $1 | $1.05 | $0.99 | 26,787 | 07-03-2024 |
$1.04 | $1 | $1.04 | $1.04 | $0.99 | 55,434 | 07-02-2024 |
$0.9725 | $1.02 | $0.9725 | $1.0299 | $0.97 | 50,134 | 07-01-2024 |
$1.01 | $0.99 | $1.01 | $1.02 | $0.99 | 13,937 | 06-28-2024 |
$0.99 | $1 | $0.99 | $1 | $0.99 | 37,761 | 06-27-2024 |
$1.005 | $1 | $1.005 | $1.0401 | $0.995 | 33,019 | 06-26-2024 |
$1 | $1 | $1 | $1.07 | $0.99 | 81,598 | 06-25-2024 |
$0.9906 | $1.02 | $0.9906 | $1.05 | $0.9901 | 30,493 | 06-24-2024 |
$1.01 | $0.9925 | $1.01 | $1.025 | $0.985 | 38,396 | 06-21-2024 |
$0.98405 | $1.02 | $0.98405 | $1.02 | $0.9734 | 83,269 | 06-20-2024 |
$1.0291 | $1.04 | $1.0291 | $1.05 | $1.02 | 55,712 | 06-19-2024 |
$1.0291 | $1.04 | $1.0291 | $1.05 | $1.02 | 55,712 | 06-18-2024 |
$1.045 | $1.05 | $1.045 | $1.08 | $1 | 113,445 | 06-17-2024 |
$1.05 | $1.0501 | $1.05 | $1.07 | $1.0168 | 75,498 | 06-14-2024 |
$1.05 | $1.04 | $1.05 | $1.08 | $1.04 | 34,612 | 06-13-2024 |
$1.05 | $1.03 | $1.05 | $1.08 | $1.03 | 107,421 | 06-12-2024 |
$1.03 | $1.03 | $1.03 | $1.05 | $0.995 | 249,568 | 06-11-2024 |
$1.04 | $1 | $1.04 | $1.0489 | $0.9557 | 319,685 | 06-10-2024 |
$0.99 | $0.9875 | $0.99 | $1 | $0.96 | 27,964 | 06-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
ImmunoPrecise Antibodies Ltd. Company Name:
IPA Stock Symbol:
NASDAQ Market:
ImmunoPrecise Antibodies Ltd. Website:
ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, is pleased to announce the appointment of Kristin Taylor as Chief Financial Officer, effective immediately. Ms. Taylor has been serving ...
ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced that its subsidiary, BioStrand, is collaborating with PGxAI to leverage BioStrand's patented Foundation AI Model, LENS ...
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”), a leader in AI-driven biotherapeutic research and technology, today announces that its subsidiary, BioStrand, has been honored with the prestigious 2024 Impact Award,...